AzTrials
AzTrials

Dental ImplantNCT04415619

Using Buccal Pad of Fat Free Tissue Transfer With Immediate Implant Placement

A study testing Xenograft bone substitute (Osteo-biol) in people with Dental Implant, run by Alexandria University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Implants placed immediately after tooth extraction usually present challenges in obtaining soft tissue coverage with high risk of bacterial invasion, wound dehiscence and subsequently adverse effect on the success rate of the implant due to lack of primary soft tissue closure over the implant. Read more about this study

Who is it for?
Ages 20 to 45 years
Conditions the study is for
Dental Implant
What is being tested?
Xenograft bone substitute (Osteo-biol)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
No sites listed yet
Study dates
1 Jul 2020to 20 Nov 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients age between 20-45 years with no gender predilection.
  • Patients with non-restorable maxillary posterior tooth which need to be extracted (premolar -molar region).
  • Patients with good oral hygiene.
  • Bony defects more than 2 mm during implant placement treated by bone substitute.
  • Patients fully capable to comply with the study protocol.

Who cannot join

  • Patients with any systemic disease affecting bone quality as uncontrolled diabetes.
  • Heavy smokers (more than 20 cigarettes per day).
  • Sites with acute oral infection.
  • Pregnant and lactating patients.
  • Untreated periodontal disease.
  • Previous chemotherapy or irradiation of the head and neck.
  • Inadequate interocclusal space.

Trial locations and contacts

No sites are listed yet.

Dina Y. Attia, MSc contact

+01017510444

dina.youssef29@gmail.com

Lobna Elwan, BSc contact

lobnaelwan@gmail.com

About this study

Official title: Evaluation of Using Buccal Pad of Fat Free Tissue Transfer With Immediate Implant Placement in the Maxillary Posterior Area

Implants placed immediately after tooth extraction usually present challenges in obtaining soft tissue coverage with high risk of bacterial invasion, wound dehiscence and subsequently adverse effect on the success rate of the implant due to lack of primary soft tissue closure over the implant.

Different surgical methods have been described to achieve primary soft tissue closure in maxillary fresh socket, each having its advantages and disadvantages, based on that, buccal pad of fat can solve this soft tissue coverage problem with minimal complications and high success rate of the placed implants.The objective of this study is to evaluate the use of buccal pad of fat tissue with immediate implant placement in the posterior maxillary area.

Read the detailed description

Ten patients will be selected randomly from the outpatient clinic, Alexandria University seeking for an immediate implant placement. The sample will be selected to match the inclusion and exclusion criteria. It will be operated upon in the Oral and Maxillofacial Department, Faculty of Dentistry, Alexandria University. One stage surgery will include tooth extraction, placement of an immediate implant, bone grafting material and autologous soft tissue graft from the buccal pad of fat. Patients will be assessed clinically and radiographically to evaluate bone and soft tissue measurements.

Conditions
Dental Implant
Being tested
Xenograft bone substitute (Osteo-biol)
Keywords
Implant, Buccal fat pad, Immediate

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Xenograft bone substitute (Osteo-biol)Procedure or surgery

    Also called Implant(Superline®,DentiumCoTM), Osstell(ISQ®)

    Xenograft bone substitute will be placed over the implant to cover the bone defect after extraction.

Study groups in NCT04415619
Study groupRoleWhat they receive
Intervention groupExperimental10 patients will have immediate implant placement with buccal pad of fat free tissue
Receives: Procedure: Xenograft bone substitute (Osteo-biol)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluate postoperative pain when using the buccal pad of fat free tissue graft for primary soft tissue coverage with immediate implant placement in the posterior maxillary area.

    Postoperative pain will be recorded by each patient after 2, 6, and 12 hours postoperatively, then daily for the first week using:

    a 10-point Visual Analogue Scale (VAS) (17) from 0 to 10 (0 no pain, to 10 severe pain).

    Measured: 6 months

  2. Evaluate swelling when using the buccal pad of fat free tissue graft for primary soft tissue coverage with immediate implant placement in the posterior maxillary area.

    Postoperative swelling will be recorded by each patient after 2, 6, and 12 hours postoperatively, then daily for the first week using a 10-point scale with 4 parameters will be used: none (no swelling), light (intraoral, localized to the treated area), moderate (extraoral swelling localized to the treated area), and severe (extraoral swelling extending beyond the treated area)

    Measured: 6 months

  3. Evaluate soft tissue healing when using the buccal pad of fat free tissue graft for primary soft tissue coverage with immediate implant placement in the posterior maxillary area.

    Evaluation of soft tissue healing

    At week 1, week4 and at 6 months:

    Presence/absence of postoperative complications will be evaluated, including:

    Bleeding, hematoma, wound dehiscence, local infection, partial flap necrosis, excessive granulation tissue or vestibular obliteration, edema, facial asymmetry and mouth opening limitation.

    Measured: 6 months

  4. Evaluate implant stability when using the buccal pad of fat free tissue graft for primary soft tissue coverage with immediate implant placement in the posterior maxillary area

    Implant stability will be measured by implant stability meter (OsstellTM), immediately postoperative and after 6 months.

    Measured: 6 months

  5. Radiographic evaluation for using the buccal pad of fat free tissue graft for primary soft tissue coverage with immediate implant placement in the posterior maxillary area.

    After 3 months then at 6 months Cone Beam CT will be requested in order to measure:

    • Bone density.
    • Amount of bone buccally and palatally to the implant.
    • Marginal bone loss.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jun 2020
  2. Study start1 Jul 2020 (estimated)
  3. Primary completion13 Oct 2020 (estimated)
  4. Study completion20 Nov 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
A group of 10 patients will receive immediate implant placement with buccal pad of fat coverage
Masking
None (open label)
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04415619
Sponsor's protocol ID
Buccal pad of fat free tissue
Status last verified
Jun 2020
First submitted
27 May 2020
Last updated
4 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Penarrocha-Diago M, Alonso-Gonzalez R, Aloy-Prosper A, Penarrocha-Oltra D, Camacho F, Penarrocha-Diago M. Use of buccal fat pad to repair post-extraction peri-implant bone defects in the posterior maxilla. A preliminary prospective study. Med Oral Patol Oral Cir Bucal. 2015 Nov 1;20(6):e699-706. doi: 10.4317/medoral.20212.

    PubMed 26241450

Questions about this trial

What is this clinical trial studying?

A study testing Xenograft bone substitute (Osteo-biol) in people with Dental Implant, run by Alexandria University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dina Y. Attia, MSc (+01017510444, dina.youssef29@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluate postoperative pain when using the buccal pad of fat free tissue graft for primary soft tissue coverage with immediate implant placement in the posterior maxillary area. (time frame: 6 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04415619, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in